Northwest Investment Counselors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.97K Buy
+46
New +$5.02K ﹤0.01% 499
2024
Q2
Sell
-46
Closed -$6.07K 518
2024
Q1
$6.07K Buy
+46
New +$5.75K ﹤0.01% 419
2023
Q4
Sell
-46
Closed -$5.16K 554
2023
Q3
$5.16K Sell
46
-20
-30% -$2.54K ﹤0.01% 437
2023
Q2
$9.61K Hold
66
﹤0.01% 397
2023
Q1
$8.53K Hold
66
﹤0.01% 414
2022
Q4
$8.41K Sell
66
-80
-55% -$9.28K ﹤0.01% 415
2022
Q3
$15K Hold
146
﹤0.01% 331
2022
Q2
$15K Hold
146
﹤0.01% 329
2022
Q1
$19K Buy
146
+78
+115% +$9.4K 0.01% 324
2021
Q4
$8K Buy
+68
New +$8.9K ﹤0.01% 402
2021
Q2
Sell
-68
Closed -$11K 464
2021
Q1
$11K Buy
+68
New +$10.5K ﹤0.01% 360
2020
Q4
Sell
-68
Closed -$9K 450
2020
Q3
$9K Buy
+68
New +$8.88K ﹤0.01% 341
2019
Q4
Sell
-47
Closed -$6K 516
2019
Q3
$6K Buy
+47
New +$6.07K ﹤0.01% 421

Other funds holding ZBH

Northwest Investment Counselors's ZBH Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Zimmer Biomet (ZBH) in Q3 2024: 46 shares worth $4.97K. The stake represents ﹤0.01% of the portfolio and ranks #499 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in ZBH as recently as Q1 2024.

Northwest Investment Counselors first reported a position in ZBH in Q3 2019 and has held it in 13 quarters since. The position peaked at $19K in Q1 2022. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Northwest Investment Counselors held 46 shares of Zimmer Biomet worth $4.97K as of Q3 2024.
  • Zimmer Biomet was a new Northwest Investment Counselors position in Q3 2024.
  • Zimmer Biomet made up ﹤0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #499 holding.
  • Northwest Investment Counselors first reported a position in Zimmer Biomet in Q3 2019 and has held it in 13 quarters since.
  • Northwest Investment Counselors's Zimmer Biomet position peaked at $19K in Q1 2022.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.